Our proprietary ACM technology allows us to produce tailor-made membrane protein products and discovery programs centered around ‘hard’ or ‘difficult-to-express’ targets in drug and vaccine discovery. Examples of membrane proteins that we handle are G protein-coupled receptors (GPCRs), ion channels or transporters, and viral antigens. Most of these membrane protein targets cannot reliably be produced using cell-lines and structurally unstable once produced. ACM technology provides enhanced stability and high yields of these targets.

ACM Biolabs mission is to de-risk discovery and development of new drugs by strategically deploying ACM technology. Our area of expertise is focused on producing novel membrane protein targets as well as their functional and structural characterization using in-house developed assays.